Sinopharm Holding Appoints New Chairman and President Following Leadership Changes

Sinopharm Holding (HKG: 1099) has announced significant changes in its leadership with the approval of its board of directors for the appointment of Zhao Bingxiang as the new chairman and Lian Wanyong as the president. This comes as former chairman Yu Qingming and president Liu Yong have stepped down from their positions due to work requirements.

Zhao Bingxiang, born in 1972, is an accomplished professional with a background in pharmacy, having graduated from Shenyang Pharmaceutical University’s School of Pharmacy. His experience includes a notable tenure at China Resources Sanjiu, where he held roles as a director, member of the Strategic Investment Committee, and president before departing in March of this year.

Lian Wanyong brings a wealth of experience within Sinopharm Holdings and its subsidiaries to his new role as president. His previous positions include director, president, and deputy party secretary of Shanghai Shyndec Pharmaceutical Co. Ltd., as well as directorships at China National Accord Medicines Corporation Ltd. and Sinopharm Group.- Flcube.com

Fineline Info & Tech